To analyze literature on sexual pain disorders and to review and summarize the articles published throughout 2013 which contribute to the current knowledge on this subject.
INTRODUCTION
'Genito-pelvic pain/penetration disorder (GPPD)' is a common, distressing complaint in women of all ages that is underrecognized and undertreated. The incidence of such dysfunction has been studied only fragmentarily ] found that, by age 40, 7.8% of women reported vulvar pain (see Table 1 ).
This condition has broad implications for a woman's well-being. It can impact her mental and physical health, relationships, ability to work and more; additionally, women with provoked vestibulodynia (PVD) report significantly lower levels of sexual functioning in comparison with control women [3] . As most people in the general population -and many healthcare professionals (HCPs) -are unaware of the severity and wideranging effects of dyspareunia, affected women may have a difficult time obtaining support. A recent survey [4] , for example, revealed that physicians are moderately comfortable treating vulvodynia within their practice and refer mostly for treatment failure. Vaginismus, now included in GPPD, was also considered the cause of unconsummated marriages, even if recent findings suggest that the female difficulty should not be seen as the primum movens but as a potential contributory cause together with partner sexual difficulties [5] .
Given the high prevalence of chronic genital pain and the relative lack of knowledge about this condition within the medical community [6 
DIAGNOSIS, ASSESSMENT AND DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION, DISCUSSION
In the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) [7] , vaginismus and dyspareunia were considered as two different diagnostic entities. The significant overlap between vaginismus and superficial dyspareunia on symptom dimensions reported in literature made it almost impossible to reliably differentiate one from the other, leaving the clinicians to consider whether they might lie on the same continuum with superficial dyspareunia sometimes extending to vaginismus [8] . Because of this marked overlap in symptoms, they have been combined in the DSM-5 into GPPD [9] .
The new diagnostic criteria [10 && ] describe the following different symptoms: difficulties with vaginal penetration during intercourse; vulvovaginal or pelvic pain during vaginal intercourse or penetration attempts; fear or anxiety about vulvovaginal or pelvic pain in anticipation of, during or as a result of vaginal penetration; tensing or tightening of the pelvic floor muscles during attempted vaginal penetration. Sungur and Gündüz [9] report that overall, merging superficial dyspareunia and vaginismus into GPPD in DSM-5 is welcomed by many professionals, whereas some debate that they can be different entities on the same continuum, with lifelong and generalized vaginismus associated with high anxiety and avoidance at one end of the spectrum and painful intercourse with high pelvic floor tension on the other end [11] .
Despite these diagnostic changes, all the articles published last year that we considered for this review continue to refer to these problems as different conditions and with different terms.
Vulvodynia is an umbrella term to define genital pain that has no clear etiology and treatment. Subtypes are often defined on the basis of their pain location: localized vulvodynia refers to pain in a particular part of the vulva, such as the vestibule (i.e., vaginal entrance) or clitoris, and generalized vulvodynia (GVD) refers to pain affecting the entire vulvar region. The pain can be further specified according to when it occurs: provoked (the pain occurs in response to external stimulation, e.g., pressure), unprovoked (spontaneous pain, occurs independently of stimulation) and mixed (a combination of provoked and unprovoked pain presentation). Two common subtypes of vulvodynia have been identified and studied: PVD, previously known as vulvar vestibulitis syndrome and sometimes termed localized provoked vulvodynia, and GVD.
The primary differences of such conditions with vaginismus were the presence of fear/avoidance as well as muscle tension being so pronounced to prevent penetration [6 & ]. Recent research has indicated that women with vaginismus respond differently to sexual stimuli compared to women with dyspareunia and women with pain-free intercourse. They express lower ratings of pleasant feelings and greater endorsement of negative emotions, such as annoyance, threat, disgust, anxiety, in response to erotic films and slides depicting intercourse [12 && ,13] .
A study [14] using functional MRI was conducted to examine whether women with vaginismus show stronger convergence in their responses toward sexual penetration and disgust-related pictures compared to sexually asymptomatic women and women suffering from vulvar pain. At a subjective level, both clinical groups rated penetration stimuli as more disgusting than asymptomatic women. Surprisingly, the brain responses to penetration stimuli did not differ between groups. The authors assume the alleged female ambiguity toward penetration can be a possible explanation for the lack of vaginismus-specific brain responses: a default disgust response tendency could, generally, prevail in women in the absence of sexual-specific interest and readiness.
KEY POINTS
Because of the marked overlap in symptoms, vaginismus and dyspareunia have been combined in the DSM-5 into 'GPPD'.
Psychosocial, cultural, sexual and biological factors can, independently or in combination, cause the establishment and maintenance of GPPD.
There is no evidence in support of the superiority of any treatment for GPPD. Women with dyspareunia reported more limited sexual desire and lubrication and fewer positive penetration-related cognitions compared to the women with vaginismus; they also reported greater sexual anxiety than the control group [13] .
In general, several guidelines should be kept in mind when assessing these conditions. HCPs should encourage their patients to begin by describing how and when they noticed their pain developing, how it progressed and what their current set of symptoms looks like. Rating the severity on a scale from 0 (no pain at all) to 10 (worst pain ever felt) is useful for assessment as well as for treatment monitoring. It is also relevant to discern how the patient has already tried to alleviate the pain. In addition to ascertaining a woman's current pain profile, HCPs should establish what situations are most likely to cause pain. For all women with vulvodynia, there might be certain external factors that trigger the pain, such as stressors or mood. For women with GVD, it is important to know whether their pain is constant or fluctuating and when those fluctuations are most likely to occur. For women with PVD, it is important to know whether their pain is evoked by certain types of contact/penetration (e.g., manual vs. phallic, intercourse position, arousal/anxiety levels). Identifying such factors assists in selecting treatment options and goals that target each woman's particular pain profile. Although a woman's self-reported symptoms and history are the most relevant source of such information, HCPs should take care to confirm their reports, whenever possible, either through medical records, performing their own physical examination, or through third-party informants (e.g., a woman's partner). In addition to identifying pain characteristics and history, it is important to isolate other psychosocial factors that might exacerbate the pain. The identification of such factors could be ascertained during both clinical interviews and the administration of validated questionnaires [6 & ].
ETIOLOGY
The etiology of GPPD is multifaceted. Psychosocial, cultural, sexual and biological factors can, independently or in combination, cause the establishment and maintenance of GPPD [1 & ]. No single etiology has been identified, and different women suffering from similar pain presentations will often describe very different pain development patterns. Similarly, those describing parallel etiologies may report very different pain presentation [6 & ].
To provide an overview of the most common somatic disorders causing genital sexual pain see Table 2 . 
Dyspareunia and vulvodynia
An association was found between dysmenorrhea and noncyclic pelvic pain, suggesting that menstrual pain is an etiological factor in noncyclic pelvic pain [15 & ]. Moreover, two important studies revealed that aspects of sexual self-schema (negative self-image cognitions about vaginal penetration, negative body image and negative genital self-image) are associated with increased pain intensity, sexual dysfunction and sexual distress [16 && ,17] . Three Canadian studies [18 & ,19,20] examined the role of partner-perceived self-efficacy and 
Interstitial cystitis
Commonly reported in patients with dyspareunia.
Female genital mutilation
Aside from dyspareunia, other severe adverse effects occur and for many women, lifelong suffering.
Gynecological cancer therapy
Pelvic radiation and chemotherapy causes fibrosis and atrophy of the lower genital tract, hampering lubrication and causing dyspareunia.
Cancer chemotherapy Causes atrophy of the vaginal mucosa; local estrogen therapy is cautioned in women with breast cancer.
Graft vs. host reaction Reported adverse effect in the vagina after systemic immunosuppressive treatment.
Malformations
Vaginal septum, congenital abnormalities.
Hidradenitis suppurativa
Chronic scarring in severe cases.
Uterine fibroid Pressure pain of the bladder and intestine, mainly deep dyspareunia.
Irritable bowel syndrome
Comorbid in women with localized provoked vulvodynia.
Pelvic radiation
Causes atrophy, agglutination, decreased lubrication and dryness, superficial as well as deep dyspareunia.
partner catastrophizing in the experience of pain, sexual functioning and sexual satisfaction of women with entry dyspareunia and with PVD. Higher levels of partner-perceived self-efficacy and lower levels of partner tragic attitude were associated with less pain intensity in women with entry dyspareunia, independent of women's pain perception and self-efficacy [18 & ]. Rosen et al. [19] , studying women with PVD, found that participant's tragic feeling and self-efficacy partially mediated the association between higher participant-perceived solicitous responses and higher pain intensity. Similarly, partner catastrophizing and self-efficacy partially mediated the association between higher partner-perceived solicitous responses and higher pain intensity in women with PVD. Solicitous partner responses may have opposing effects. On one hand, they can generate cognitions that the pain is uncontrollable and may lead to further avoidance of sexual activity: partner solicitousness may encourage avoidance of sexual intercourse and/or exacerbate vulvovaginal pain by increasing catastrophizing and decreasing self-efficacy. On the other hand, solicitous responses may lead to greater sexual satisfaction because women interpret these responses as reflecting partner sensitivity and understanding of their pain, resulting in greater sexual satisfaction. In contrast, women may interpret negative partner responses as a lack of sensitivity to their pain, thereby creating a detrimental context for sexual activity, resulting in lower sexual satisfaction. Dyadic adjustment partially mediated the association between higher participant-perceived solicitous responses and higher sexual satisfaction, and fully mediated the association between higher participant-perceived negative responses and lower sexual satisfaction.
A third study [20] labelled male partner responses to painful intercourse into three different kinds of responses: solicitous (attention and sympathy), negative (hostility and frustration) and facilitative (encouragement of adaptive coping). The findings suggest that facilitative male partner responses may improve sexual functioning, whereas solicitous and negative responses may be detrimental.
Vaginismus
An Italian study [21 && ] aimed to measure the prevalence of alexithymia and emotional dysregulation in women with vaginismus. The cumulative percentage of patients with alexithymic trend was 51.1%, indicating that a considerable number of women with vaginismus react in such a way as to suggest that their capacity for emotional processing is partly or completely absent. In contrast, the cumulative percentage of alexithymic and borderline scores in the control group was just 18%, significantly lower than in the patient group. In terms of relative risk, women suffering from vaginismus thus have a 3.8 times higher probability of showing alexithymia than healthy women. The subanalysis showed a significant difference between the groups for TAS-20 subscale F1 (difficulty identifying feelings), F2 (difficulty in expressing feelings) and F3 (externally oriented thinking). Women with vaginismus essentially demonstrated poor cognitiveemotional processing, which seemed to be indicative of a tendency to somatization. This group also tended to have a concrete, logical cognitive thinking style not mediated by any reflective function. However, there was no significant difference between the groups in describing feelings, such as joy or uneasiness, to others. Because of the high incidence of alexithymia, it must thus be considered as a risk factor in some patients affected with vaginismus, as this personality trait could exacerbate and perpetuate this psychogenic sexual dysfunction.
Melles et al. [22 && ], supporting the importance of fear in vaginismus, found that women with such dysfunction showed relatively stronger fear associations with sexual stimuli at the subjective (deliberate) level but not at the more automatic level. The initial (automatic) appraisals are proposed to follow from the direct activation of simple associations in memory, whereas the more deliberate appraisals are assumed to be the result of more controlled, reflective processes. Moreover, women with vaginismus also showed less positive self-reported global affective associations with sexual stimuli, whereas at the automatic level, they showed similarly positive global affective associations with sexual stimuli as women without vaginismus.
Vaginismus, in contrast to superficial vulvodynia, is probably best described as a phobic defense mechanism -perhaps often elicited by psychosexual negative experiences [1 & ]. 
IMPLICATIONS FOR TREATMENT

Dyspareunia and vulvodynia
The multifactorial nature of vulvodynia therefore often calls for a multidisciplinary approach to establish a valid diagnosis and appropriate treatment ] tried to investigate one of the possible causes that could lead women not to seek care for chronic vulvar pain: the perceived stereotyping. The hypothesis was that perceived stereotyping regarding vulvar pain sufferers, which may ultimately lead to stigma, could contribute to estrangement from healthcare providers. The results of the study do not suggest that the perception of stereotyping from physicians or other people was the barrier to seeking care. In fact, women who sought care were more likely to have a poor perception of physicians' stereotyping opinions. These findings suggest that other causes influencing the failure to seek care for chronic vulvar pain should be investigated.
A Canadian study [24 && ] was carried out to assess changes over a 2-year period in pain, depressive symptoms and sexual outcomes in women with PVD and examine changes based on treatment(s) type. They took into consideration various types of treatment (physical therapy, sex therapy/psychotherapy, medical management, surgery, acupuncture, other, multiple, no treatment) finding that all treatments except acupuncture, which showed a minor efficacy, were associated with significantly lower pain levels after 2 years, including the 'no treatment' group.
Considering that there appears to be a significant advance in pain over time without treatment, it is imperative that randomized trials yield an improvement above and beyond what appears to be the natural progression of PVD. Although pain reduction is an important goal in treatment of PVD, once the pain is reduced, further treatment tailored to the individual or couple may be needed to improve other aspects of quality of life. This may be a way in which some of the treatments outperform the no treatment group, as the no treatment group did not progress significantly on any psychosexual measures, whereas other treatment groups did.
A multimodal pain-driven management model is recommended, although the treatment literature is still sparse. Treatment aims should be decided upon collaboratively and may extend beyond pain relief.
Psychotherapy can be used to target specific cognitive, emotional, relational and behavioral goals related to the experience of chronic pain. It is of particular benefit as it is noninvasive and does not cause unwanted side-effects. Psychotherapy is recommended if patients report unwanted cognitions or behaviors, have a difficult time emotionally and/or experience sexual and relationship difficulties. There are many different types of psychotherapy that could be applied to vulvodynia, although few have received rigorous research attention. In general, a flexible treatment approach that addresses both pain and sexuality issues should be applied, as each patient brings a unique pain profile, and may experience the impact of the pain in varying ways [6 & ]. The practice of mindfulness-based cognitive therapy has also garnered attention in the treatment of dyspareunia [25 && ]. Techniques that help patients remain in the moment and find ways to tolerate and accept their pain have been growing in popularity. Such approaches also assist patients to become more attuned to the factors that increase or decrease their pain and encourage them to also attend to positive events in their life and relationship. Finally, some patients would greatly benefit from sex or couples therapy. Ideally, the therapy would target the pain in a collaborative manner. Such a practice could involve improving communication, reducing feelings of guilt or shame and building positive sexual encounters while managing pain. Partners can be instructed in assisting with mindfulness or distraction to cope with the pain. Elements of couples therapy could be incorporated into individual therapy if the patient does not wish to have her partner present at every session. Addressing dyadic factors early in the management course of entry dyspareunia may improve the success of therapeutic interventions [18 & ]. There is limited evidence that antidepressants and anticonvulsants are helpful for women with vulvodynia [26 & ,27 & ]. Some have hypothesized that such medications might be more useful for women with GVD as their pain is more constant, and others suggest that further research is required to determine particular combinations of medical therapy to treat specific pain presentations. If a patient has a comorbid mood and/or anxiety disorder, the administration of appropriate medication may assist in reducing symptoms of those disorders, which might in turn improve a patient's pain experience. It is optimal to offer pharmacotherapy in concert with psychotherapy [6 & ].
Vaginismus
Psychotherapeutic techniques targeting phobias can be adapted to situations that evoke such a fear response and avoidance in women with vaginismus [6 & ]. Although there is currently no conclusive evidence on this area of debate, the reasonable evidence that cognitive behavioral therapy may alleviate or eliminate 'vaginismus' appears to support the relationship between vaginismus and phobia. Fear of pain should be addressed as it can be an important component of vaginismus. Furthermore, screening for depression and anxiety is recommended [1 & ]. Counselling could help explore the alexithymic trait as part of an integrated treatment regime for vaginismus [21 && ]. Exposure therapy was found to be very effective in reducing symptoms of vaginismus and in amplifying the selfreported global positive affective associations with sexual stimuli, whereas the automatic associations remained unaffected [22 && ,28 & ]. Sex therapy based on cognitive behavioral methods has resulted in success [29] .
A preliminary study [30 & ] indicates that physical therapy may also be a promising intervention in the treatment of vaginismus, even if prospective treatment outcome studies are necessary.
CONCLUSION
DSM-5 has combined vaginismus and dyspareunia into the same diagnostic label. The research reviewed in this article seems to differently point toward two conditions, focusing on different aspects both on the etiological and on the treatment areas. The present findings did not provide clear evidence in support of the superiority of any treatment and highlight the need for randomized, placebocontrolled trials that compare treatments in the future [24 && ]. A lot of work remained to be done to understand such a complex and multifaceted disturb like female GPPD, but the articles examined showed that we are slowly adding more knowledge on the etiological cause and treatment models for such conditions. In line with emergent findings on the differences between vaginismus and dyspareunia, the results of this review may call into question a combination of the disorders into GPPD.
